[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Bacteremia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Bacterial (Pyogenic) Meningitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacterial Pneumonia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Bacterial Pneumonia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Bacterial Vaginosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for B-Cell Chronic Lymphocytic Leukemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for B-Cell Lymphomas. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 150 pages

Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Behcet's Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Biliary Tumor. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Bipolar Disorder (Manic Depression). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Birch Pollen Allergy - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Birch Pollen Allergy The report also ...

January 2020 120 pages

Blepharitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Blepharitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Cervical Dysplasia - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Cervical Dysplasia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cervical Dysplasia development. The report provides ...

January 2020 60 pages

Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Chemotherapy Induced Anemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Chronic Bronchitis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Chronic Bronchitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chronic Bronchitis development. The report provides ...

January 2020 60 pages

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Chronic Kidney Disease (Chronic Renal Failure) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Chronic Kidney Disease (Chronic Renal Failure). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Chronic Liver Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Chronic Pancreatitis Pain - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Pancreatitis Pain The report also ...

January 2020 60 pages

Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Chronic Plaque Psoriasis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Chronic Thromboembolic Pulmonary Hypertension - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Thromboembolic Pulmonary Hypertension The report also ...

January 2020 60 pages

Chronic Urticaria Or Hives - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Urticaria Or Hives The report also ...

January 2020 90 pages

Cryptococcosis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Cryptococcosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cryptococcosis development. The report provides detailed ...

January 2020 60 pages

Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Cystitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Dental Pain - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Dental Pain - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dental Pain development. The report provides ...

January 2020 60 pages

Dyspepsia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Dyspepsia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Dystonia - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Dystonia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dystonia development. The report provides detailed ...

January 2020 60 pages

Emphysema - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Emphysema - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Emphysema development. The report provides detailed ...

January 2020 60 pages

Endometriosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Endometriosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Epithelial Ovarian Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Equine Encephalitis - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Equine Encephalitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Equine Encephalitis development. The report provides ...

January 2020 60 pages

Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Erectile Dysfunction. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Esophageal Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Fabry Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Familial Adenomatous Polyposis Coli The report also ...

January 2020 120 pages

Febrile Neutropenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Febrile Neutropenia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Gastric Ulcers. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Gastritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Gastritis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Gastrointestinal Stromal Tumor (GIST) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Gastrointestinal Stromal Tumor (GIST). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Gastroparesis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Gastroparesis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Guillain-Barre Syndrome - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Guillain-Barre Syndrome - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Guillain-Barre Syndrome development. The report provides ...

January 2020 60 pages

H1N1 infection - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'H1N1 infection - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across H1N1 infection development. The report provides ...

January 2020 60 pages

H3N2 Infection - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'H3N2 Infection - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across H3N2 Infection development. The report provides ...

January 2020 90 pages

Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Hairy Cell Leukemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Helicobacter Pylori Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Hematopoietic Stem Cell Transplantation. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2020

 US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hematopoietic Stem Cell Transplantation The report also ...

January 2020 60 pages

Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Hemophilia B. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Hemophilia B - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Hemophilia B - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hemophilia B development. The report provides ...

January 2020 90 pages

Hemorrhagic Shock - Pipeline Insight, 2020

 US$ 1,250.00

... clients within 48 Hours 'Hemorrhagic Shock - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hemorrhagic Shock development. The report provides ...

January 2020 60 pages

Hemostasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

 US$ 2,000.00

... marketed and Phase III products for Hemostasis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1